SCHEMBL6528199

SCHEMBL6528199

COC(=O)[C@@H](CC(C)C)Nc1nc(NCc2cccc(F)c2)nc(Oc2ccc(OC)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.43
TP53 P04637 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TAS1R3 Q7RTX0 3/20 0.39
TAS1R1 Q7RTX1 3/20 0.39
CYP2C9 P11712 1/20 0.39
NPR3 P17342 1/20 0.39
CYP2C19 P33261 1/20 0.39
CTSK P43235 2/20 0.38
CTSL P07711 1/20 0.38
CTSS P25774 1/20 0.38
AURKA O14965 1/20 0.38
RPS6KB1 P23443 1/20 0.38
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MAPT P10636 1/20 0.37
SLC26A6 Q9BXS9 1/20 0.37
KCNH3 Q9ULD8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6528195 1.00 ANPEP (0.43) ANPEPTP53MEN1KMT2ATAS1R3
SCHEMBL6530303 0.89 VNN1 (0.44) ANPEPTAS1R3TAS1R1CYP2C9NPR3
SCHEMBL6529952 0.79 NPR3 (0.42) TP53MEN1KMT2ATAS1R3TAS1R1
SCHEMBL6529959 0.79 NPR3 (0.42) TP53MEN1KMT2ATAS1R3TAS1R1
SCHEMBL6530426 0.78 ALDH1A1 (0.47) TP53CYP2C9CYP2C19CTSKCTSS
SCHEMBL6530423 0.78 ALDH1A1 (0.47) TP53CYP2C9CYP2C19CTSKCTSS
SCHEMBL6529224 0.78 NPR3 (0.56) ANPEPMEN1KMT2ATAS1R3TAS1R1
SCHEMBL8298689 0.76 CYP2C9 (0.44) TP53TAS1R3TAS1R1CYP2C9NPR3
SCHEMBL6528805 0.76 CYP2C9 (0.44) TP53TAS1R3TAS1R1CYP2C9NPR3
SCHEMBL6530084 0.76 RORC (0.45) CYP2C9CYP2C19CTSKKCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed